November 10-15

The official news source of

ACR Convergence 2023

San Diego, CA

Home // Recognizing Autoimmune Interstitial Lung Diseases (ILDs)

Recognizing Autoimmune Interstitial Lung Diseases (ILDs)


1 minute

Friday, November 6, 2020 | 6:00 PM EST
Supported by Boehringer Ingelheim Pharmaceuticals, Inc.


Primary Session Topic:
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)

Session Description:
Upon completion of this session, participants should be able to:

  • Provide an overview on common autoimmune-associated ILDs and the impact of these ILDs on patients
  • Improve the identification of patients with potential autoimmune-associated ILDs in order to support a timely and accurate diagnosis
  • Review case examples with HRCT images of autoimmune-associated ILDs to enhance diagnosis and effective care for patients

This program is developed and offered by Boehringer Ingelheim. This is not an official program of the American College of Rheumatology.

Session Speakers:
Chase S. Correia, MD
Felipe Martinez, MD